Dokument: Pluripotent stem-cell-based screening uncovers sildenafil as a mitochondrial disease therapy

Titel:Pluripotent stem-cell-based screening uncovers sildenafil as a mitochondrial disease therapy
URL für Lesezeichen:https://docserv.uni-duesseldorf.de/servlets/DocumentServlet?id=72938
URN (NBN):urn:nbn:de:hbz:061-20260414-095935-1
Kollektion:Publikationen
Sprache:Englisch
Dokumententyp:Wissenschaftliche Texte » Artikel, Aufsatz
Medientyp:Text
Autoren: Zink, Annika [Autor]
Heiduschka, Sonja [Autor]
Petersilie, Laura [Autor]
Jerred, Caleb [Autor]
Neu, Louis Anton [Autor]
Tolle, Isabella [Autor]
Herebian, Diran [Autor]
Cecchetto, Giulia [Autor]
Mayatepek, Ertan [Autor]
Distelmaier, Felix [Autor]
Dateien:
[Dateien anzeigen]Adobe PDF
[Details]24,85 MB in einer Datei
[ZIP-Datei erzeugen]
Dateien vom 14.04.2026 / geändert 14.04.2026
Beschreibung:Mitochondrial disease encompasses inherited disorders affecting mitochondrial function. A severe and untreatable form of mitochondrial disease is Leigh syndrome (LS), causing psychomotor regression and metabolic crises. To accelerate drug discovery for LS, we screen a library of 5,632 repurposable compounds in neural cells from LS-patient-derived induced pluripotent stem cells (iPSCs). We identify phosphodiesterase type 5 (PDE5) inhibitors as leads and prioritize sildenafil for its clinical safety. Sildenafil corrects mitochondrial membrane potential defects, restores neurodevelopmental pathways, and normalizes calcium responses in LS brain organoids. In small and large mammalian models of LS, sildenafil extends lifespan and ameliorates disease phenotypes. Off-label treatment on an individual basis with sildenafil in six LS patients improves their motor function and resistance to metabolic crises. Collectively, the findings highlight the potential of iPSC-driven drug discovery and position sildenafil as a promising drug candidate for mitochondrial disease.
Rechtliche Vermerke:Originalveröffentlichung:
Zink, A., Dai, D.-F., Wittich, A., Henke, M.-T., Pedrotti, G., Heiduschka, S., Santamaria, G., Pentimalli, T. M., Brueser, C., Notopoulou, S., Umar, A. R., Zhaivoron, A., Petersilie, L., Jerred, C., Bergmans, J., Neu, L. A., Schumacher, F., Keller-Findeisen, J., Rybak-Wolf, A., … Prigione, A. (2026). Pluripotent stem-cell-based screening uncovers sildenafil as a mitochondrial disease therapy. Cell, 189(6), 1656-1679.e42. https://doi.org/10.1016/j.cell.2026.02.008
Lizenz:Creative Commons Lizenzvertrag
Dieses Werk ist lizenziert unter einer Creative Commons Namensnennung 4.0 International Lizenz
Fachbereich / Einrichtung:Medizinische Fakultät
Dokument erstellt am:14.04.2026
Dateien geändert am:14.04.2026
english
Benutzer
Status: Gast
Aktionen